clinical trial · NCT02493322
Efficacy and Safety of Olmesartan Associated With Chlorthalidone in Essential Arterial Hypertension Control
EMS·phase3·withdrawn
Essential Arterial HypertensionOlmesartan Medoxomil 20mg + Chlorthalidone 12,5mgOlmesartan medoxomil 20mg + Chlortalidone 25mgOlmesartan 20mg + hydrochlorothiazide 12,5mg
brief summary
The purpose of this study is to evaluate the non-inferiority clinical efficacy of two different drug associations in the essential hypertension control.
started
—
primary completion
Jun 1, 2025
completion
—
last updated
Dec 8, 2025
official title
Efficacy and Safety Evaluation of the New Association on Fixed Dose of Olmesartan + Chlorthalidone, Produced by EMS S.A,in Arterial Hypertension Control
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol